The Src homology 2 domain of Vav is required for its compartmentation to the plasma membrane and activation of C-jun NH2-terminal kinase 1

被引:69
作者
Arudchandran, R
Brown, MJ
Peirce, MJ
Song, JS
Zhang, JA
Siraganian, RP
Blank, U
Rivera, J
机构
[1] NIAMSD, Sect Chem Immunol, NIH, Bethesda, MD 20892 USA
[2] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA
[3] Natl Inst Dent & Craniofacial Res, Immunol Lab, NIH, Bethesda, MD 20892 USA
[4] Inst Pasteur, F-75724 Paris, France
关键词
Vav; Fc epsilon receptor I; mast cell; glycosphingolipid-enriched microdomains; plasma membrane;
D O I
10.1084/jem.191.1.47
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vav is a hematopoietic cell-specific guanine nucleotide exchange factor (GEF) whose activation is mediated by receptor engagement. The relationship of Vav localization to its function is presently unclear. We found that Vav redistributes to the plasma membrane in response to Fc epsilon receptor I (Fc epsilon RI) engagement. The redistribution of Vav was mediated by its Src homology 2 (SH2) domain and required Syk activity. The Fc epsilon RI and Vav were found to colocalize and were recruited to glycosphingolipid-enriched microdomains (GEMs). The scaffold protein, linker for activation of T cells (LAT), and Rad (a target of Vav activity) were constitutively present in GEMs. Expression of an SH2 domain-containing COOH-terminal fragment of Vav inhibited Vav phosphorylation and movement to the GEMs but had no effect on the tyrosine phosphorylation of the adaptor protein, SLP-76 (SH2 domain-containing leukocyte protein of 76 kD), and LAT. However, assembly of the multiprotein complex containing these proteins was inhibited. In addition, Fc epsilon RI-dependent activation of c-Jun NH2-terminal kinase 1 (JNK1) was also inhibited. Thus, Vav localization to the: plasma membrane is mediated by its SH2 domain and may serve to regulate downstream effectors like JNK1.
引用
收藏
页码:47 / 59
页数:13
相关论文
共 65 条
[1]   Polyethylene glycol-mediated infection of non-permissive mammalian cells with semliki forest virus: application to signal transduction studies [J].
Arudchandran, R ;
Brown, MJ ;
Song, JS ;
Wank, SA ;
Haleem-Smith, H ;
Rivera, J .
JOURNAL OF IMMUNOLOGICAL METHODS, 1999, 222 (1-2) :197-208
[2]  
BENHAMOU M, 1993, J BIOL CHEM, V268, P23318
[3]   Increasing complexity of Ras signaling [J].
Campbell, SL ;
Khosravi-Far, R ;
Rossman, KL ;
Clark, GJ ;
Der, CJ .
ONCOGENE, 1998, 17 (11) :1395-1413
[4]   The real LAT steps forward [J].
Cantrell, D .
TRENDS IN CELL BIOLOGY, 1998, 8 (05) :180-182
[5]  
Collins TL, 1997, IMMUNOL TODAY, V18, P221
[6]   The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-κB pathways [J].
Costello, PS ;
Walters, AE ;
Mee, PJ ;
Turner, M ;
Reynolds, LF ;
Prisco, A ;
Sarner, N ;
Zamoyska, R ;
Tybulewicz, VLJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (06) :3035-3040
[7]  
Costello PS, 1996, ONCOGENE, V13, P2595
[8]  
Crespo P, 1996, ONCOGENE, V13, P455
[9]   Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product [J].
Crespo, P ;
Schuebel, KE ;
Ostrom, AA ;
Gutkind, JS ;
Bustelo, XR .
NATURE, 1997, 385 (6612) :169-172
[10]   Functional and physical interactions of Syk family kinases with the Vav proto-oncogene product [J].
Deckert, M ;
TartareDeckert, S ;
Couture, C ;
Mustelin, T ;
Altman, A .
IMMUNITY, 1996, 5 (06) :591-604